Global and United States CAR T-Cell Therapy for Multiple Myeloma Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Application: 2020 VS 2026
1.3.2 Multiple Myeloma
1.3.3 Refractory or Relapsed Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Perspective (2015-2026)
2.2 Global CAR T-Cell Therapy for Multiple Myeloma Growth Trends by Regions
2.2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CAR T-Cell Therapy for Multiple Myeloma Historic Market Share by Regions (2015-2020)
2.2.3 CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Market Size
3.1.1 Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Revenue (2015-2020)
3.1.2 Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Players (2015-2020)
3.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Therapy for Multiple Myeloma Revenue
3.4 Global CAR T-Cell Therapy for Multiple Myeloma Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy for Multiple Myeloma Revenue in 2019
3.5 Key Players CAR T-Cell Therapy for Multiple Myeloma Area Served
3.6 Key Players CAR T-Cell Therapy for Multiple Myeloma Product Solution and Service
3.7 Date of Enter into CAR T-Cell Therapy for Multiple Myeloma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy for Multiple Myeloma Breakdown Data by Type (2015-2026)
4.1 Global CAR T-Cell Therapy for Multiple Myeloma Historic Market Size by Type (2015-2020)
4.2 Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Type (2021-2026)
5 CAR T-Cell Therapy for Multiple Myeloma Breakdown Data by Application (2015-2026)
5.1 Global CAR T-Cell Therapy for Multiple Myeloma Historic Market Size by Application (2015-2020)
5.2 Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2026)
6.2 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
6.3 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)
6.4 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2026)
7.2 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
7.3 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)
7.4 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2026)
8.2 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
8.3 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)
8.4 China CAR T-Cell Therapy for Multiple Myeloma Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2026)
9.2 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
9.3 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)
9.4 Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size (2015-2026)
10.2 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020)
10.3 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020)
10.4 Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Juno Therapeutics
11.1.1 Juno Therapeutics Company Details
11.1.2 Juno Therapeutics Business Overview
11.1.3 Juno Therapeutics CAR T-Cell Therapy for Multiple Myeloma Introduction
11.1.4 Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020))
11.1.5 Juno Therapeutics Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Introduction
11.2.4 Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
11.2.5 Kite Pharma Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis CAR T-Cell Therapy for Multiple Myeloma Introduction
11.3.4 Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
11.3.5 Novartis Recent Development
11.4 Collectis
11.4.1 Collectis Company Details
11.4.2 Collectis Business Overview
11.4.3 Collectis CAR T-Cell Therapy for Multiple Myeloma Introduction
11.4.4 Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
11.4.5 Collectis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Monotherapy
Table 4. Key Players of Combination Therapy
Table 5. Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions (2015-2020)
Table 9. Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions (2021-2026)
Table 11. CAR T-Cell Therapy for Multiple Myeloma Market Market Trends
Table 12. CAR T-Cell Therapy for Multiple Myeloma Market Drivers
Table 13. CAR T-Cell Therapy for Multiple Myeloma Market Challenges
Table 14. CAR T-Cell Therapy for Multiple Myeloma Market Restraints
Table 15. Global CAR T-Cell Therapy for Multiple Myeloma Revenue by Players (2015-2020) (US$ Million)
Table 16. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Players (2015-2020)
Table 17. Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Therapy for Multiple Myeloma as of 2019)
Table 18. Global CAR T-Cell Therapy for Multiple Myeloma by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Therapy for Multiple Myeloma Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020) (US$ Million)
Table 23. Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Type (2015-2020)
Table 24. Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Type (2021-2026)
Table 25. Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Application (2015-2020)
Table 26. Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020) (US$ Million)
Table 27. Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Application (2021-2026)
Table 28. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020) (US$ Million)
Table 29. North America CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2015-2020)
Table 30. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020) (US$ Million)
Table 31. North America CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2015-2020)
Table 32. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (US$ Million) (2015-2020)
Table 33. North America CAR T-Cell Therapy for Multiple Myeloma Market Share by Country (2015-2020)
Table 34. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2015-2020)
Table 36. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2015-2020)
Table 38. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Country (2015-2020)
Table 40. China CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020) (US$ Million)
Table 41. China CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2015-2020)
Table 42. China CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020) (US$ Million)
Table 43. China CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2015-2020)
Table 44. China CAR T-Cell Therapy for Multiple Myeloma Market Size by Region (US$ Million) (2015-2020)
Table 45. China CAR T-Cell Therapy for Multiple Myeloma Market Share by Region (2015-2020)
Table 46. Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2015-2020)
Table 48. Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2015-2020)
Table 50. Japan CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan CAR T-Cell Therapy for Multiple Myeloma Market Share by Country (2015-2020)
Table 52. Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2015-2020)
Table 54. Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2015-2020)
Table 56. Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Share by Country (2015-2020)
Table 58. Juno Therapeutics Company Details
Table 59. Juno Therapeutics Business Overview
Table 60. Juno Therapeutics Product
Table 61. Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020) (US$ Million)
Table 62. Juno Therapeutics Recent Development
Table 63. Kite Pharma Company Details
Table 64. Kite Pharma Business Overview
Table 65. Kite Pharma Product
Table 66. Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020) (US$ Million)
Table 67. Kite Pharma Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Product
Table 71. Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020) (US$ Million)
Table 72. Novartis Recent Development
Table 73. Collectis Company Details
Table 74. Collectis Business Overview
Table 75. Collectis Product
Table 76. Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020) (US$ Million)
Table 77. Collectis Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of FiguresFigure 1. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Application: 2020 VS 2026
Figure 5. Multiple Myeloma Case Studies
Figure 6. Refractory or Relapsed Multiple Myeloma Case Studies
Figure 7. CAR T-Cell Therapy for Multiple Myeloma Report Years Considered
Figure 8. Global CAR T-Cell Therapy for Multiple Myeloma Market Size (US$ Million), YoY Growth 2015-2026
Figure 9. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions: 2020 VS 2026
Figure 10. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions (2021-2026)
Figure 11. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Players in 2019
Figure 12. Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Therapy for Multiple Myeloma as of 2019
Figure 13. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy for Multiple Myeloma Revenue in 2019
Figure 14. North America CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 15. United States CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. Canada CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Germany CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. France CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. U.K. CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Italy CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Russia CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Nordic CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Rest of Europe CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Juno Therapeutics Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
Figure 42. Kite Pharma Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
Figure 43. Novartis Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
Figure 44. Collectis Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed